myprocessexpo365 News – Pharmaceuticalhttp://myprocessexpo365.packexpo.com/NHL-8/Pharmaceutical/Headlines.aspx2008 myprocessexpo365en-usmyprocessexpo365.com - – Food Processing Industry News, Supplier Directory, & Industry Resourceshttp://myprocessexpo365.packexpo.com/Skins/myprocessexpo365/365/logo.pnghttp://myprocessexpo365.packexpo.com/Default.aspx Food Processing News - PharmaceuticalMon, 08 Sep 2008 06:42:04 GMT60FDA Orders Stronger Warnings on Arthritis Drug Labelshttp://myprocessexpo365.packexpo.com/NST-8-50098413/FDA-Orders-Stronger-Warnings-on-Arthritis-Drug-Labels.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedFri, 05 Sep 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50098413/FDA-Orders-Stronger-Warnings-on-Arthritis-Drug-Labels.aspxThe agency is asking the makers of Humira, Cimzia, Enbrel and Remicade to emphasize the risk for developing fungal infections after uing the medications.Unilever Chief Stepping Down at Year's Endhttp://myprocessexpo365.packexpo.com/NST-8-50097755/Unilever-Chief-Stepping-Down-at-Year-s-End.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedThu, 04 Sep 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50097755/Unilever-Chief-Stepping-Down-at-Year-s-End.aspxPatrick Cescau will be succeeded by Paul Polman, who is currently the executive vice president and Zone Director for the Americas at Nestle SA.ZymoGenetics Hands Work on Arthritis Drug to Merck Seronohttp://myprocessexpo365.packexpo.com/NST-8-50097764/ZymoGenetics-Hands-Work-on-Arthritis-Drug-to-Merck-Serono.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedThu, 04 Sep 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50097764/ZymoGenetics-Hands-Work-on-Arthritis-Drug-to-Merck-Serono.aspxThe experimental biotech drug, atacicept, is also undergoing clinical trials for the treatment of lupus.FTC Clears Fresenius Acquisition of APP Pharmaceuticalshttp://myprocessexpo365.packexpo.com/NST-8-50097066/FTC-Clears-Fresenius-Acquisition-of-APP-Pharmaceuticals.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedWed, 03 Sep 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50097066/FTC-Clears-Fresenius-Acquisition-of-APP-Pharmaceuticals.aspxThe German medical device maker announced its intention to acquire APP, the leading U.S. maker of heparin, in July.Novacea and Transcept Pharmaceuticals Mergehttp://myprocessexpo365.packexpo.com/NST-8-50097067/Novacea-and-Transcept-Pharmaceuticals-Merge.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedWed, 03 Sep 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50097067/Novacea-and-Transcept-Pharmaceuticals-Merge.aspxThe all-stock deal will alow Novacea to take advantage of Transcept's drug development capabilities and give Transcept access to Novacea's sales force.Shionogi to Acquire Sciele Pharmahttp://myprocessexpo365.packexpo.com/NST-8-50096615/Shionogi-to-Acquire-Sciele-Pharma.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedTue, 02 Sep 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50096615/Shionogi-to-Acquire-Sciele-Pharma.aspxThe Japanese drugmaker will be buying its way into the U.S. pharmaceuticals market with the deal, which is valued at approximately $1.1 billion.Viva Pharmaceutical Set to Build New Plant in Washingtonhttp://myprocessexpo365.packexpo.com/NST-8-50095754/Viva-Pharmaceutical-Set-to-Build-New-Plant-in-Washington.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedFri, 29 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50095754/Viva-Pharmaceutical-Set-to-Build-New-Plant-in-Washington.aspxThe company is preparing to break ground in the town of Blaine for a facility scheduled to come online in 2009 and create 150 jobs.UCB to Cut Jobs, Refocus on Biotechhttp://myprocessexpo365.packexpo.com/NST-8-50095179/UCB-to-Cut-Jobs-Refocus-on-Biotech.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedThu, 28 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50095179/UCB-to-Cut-Jobs-Refocus-on-Biotech.aspxThe Belgian drugmaker is reducing its workforce by 2,000 and concentrating on central nervous system and immunology therapies.PharmaForce Seeking Site for New Production Facilityhttp://myprocessexpo365.packexpo.com/NST-8-50094586/PharmaForce-Seeking-Site-for-New-Production-Facility.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedWed, 27 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50094586/PharmaForce-Seeking-Site-for-New-Production-Facility.aspxThe Columbus, Ohio-based drugmaker is looking at locations in three states for a new 70,000-square-foot plant and corporate offices.Noven Recalls ADHD Patcheshttp://myprocessexpo365.packexpo.com/NST-8-50093714/Noven-Recalls-ADHD-Patches.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedTue, 26 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50093714/Noven-Recalls-ADHD-Patches.aspxThe pharmaceutical company is recalling several hundred thousand Daytrana patches because patients are having difficulty removing the liner to expose the adhesive or attaching the patch to their skin.For GSK Exec, No End to Inspirationhttp://myprocessexpo365.packexpo.com/NST-8-50093719/For-GSK-Exec-No-End-to-Inspiration.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedTue, 26 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50093719/For-GSK-Exec-No-End-to-Inspiration.aspxAndrew Witty, recently appointed GlaxoSmithKline chief executive officer, is pursuing new ways to develop drugs and bolster sales of consumer products.Alpharma Rejects Unsolicited Takeover Bid From King Pharmaceuticalshttp://myprocessexpo365.packexpo.com/NST-8-50093115/Alpharma-Rejects-Unsolicited-Takeover-Bid-From-King-Pharmaceuticals.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedMon, 25 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50093115/Alpharma-Rejects-Unsolicited-Takeover-Bid-From-King-Pharmaceuticals.aspxIn a letter sent Friday, Alpharma told King the proposal was not in its best interest.Amgen's Blood Clotting Drug Gets FDA Nodhttp://myprocessexpo365.packexpo.com/NST-8-50093128/Amgen-s-Blood-Clotting-Drug-Gets-FDA-Nod.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedMon, 25 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50093128/Amgen-s-Blood-Clotting-Drug-Gets-FDA-Nod.aspxNplate is indicated for the treatment of patients with a disorder that causes the body to attack its own platelets.Abbott Labs to Cut 1,000 Jobshttp://myprocessexpo365.packexpo.com/NST-8-50092191/Abbott-Labs-to-Cut-1-000-Jobs.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedFri, 22 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50092191/Abbott-Labs-to-Cut-1-000-Jobs.aspxThe drug and medical device maker is undertaking a multiyear effort to lower spending on its medical testing business.BMS Enters Development Deal With PDL BioPharmahttp://myprocessexpo365.packexpo.com/NST-8-50091627/BMS-Enters-Development-Deal-With-PDL-BioPharma.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedThu, 21 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50091627/BMS-Enters-Development-Deal-With-PDL-BioPharma.aspxBristol-Myers-Squibb is paying the biotech firm $30M in return for future marketing rights and some intellectual property related to PDL's experimental myeloma drug.Medtronic's First-Quarter Profit Up 11 Percenthttp://myprocessexpo365.packexpo.com/NST-8-50090969/Medtronic-s-First-Quarter-Profit-Up-11-Percent.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedWed, 20 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50090969/Medtronic-s-First-Quarter-Profit-Up-11-Percent.aspxThe company's growth was driven by sales of spinal and heart devices.Salix Trying to Raise $50 Million to Expandhttp://myprocessexpo365.packexpo.com/NST-8-50090972/Salix-Trying-to-Raise-50-Million-to-Expand.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedWed, 20 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50090972/Salix-Trying-to-Raise-50-Million-to-Expand.aspxThe drug company, which specializes in gastrointestinal treatments, plans to sell convertible senior notes to investors to raise capital to expand its product lineup.FDA Wants Pancreatitis Warning on Byetta Labelhttp://myprocessexpo365.packexpo.com/NST-8-50090303/FDA-Wants-Pancreatitis-Warning-on-Byetta-Label.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedTue, 19 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50090303/FDA-Wants-Pancreatitis-Warning-on-Byetta-Label.aspxUse of the diabetes drug marketed by Amylin Pharmaceuticals has been linked to fatal cases of the disease.Lannett Announces Immediate Availability of Bulk Packshttp://myprocessexpo365.packexpo.com/NST-8-50089654/Lannett-Announces-Immediate-Availability-of-Bulk-Packs.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedMon, 18 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50089654/Lannett-Announces-Immediate-Availability-of-Bulk-Packs.aspxThe generic drug maker is offering bulk quantities of its 22 products in a total of 43 different dosage strengths.FDA Approves Huntington's Disease Treatmenthttp://myprocessexpo365.packexpo.com/NST-8-50089674/FDA-Approves-Huntington-s-Disease-Treatment.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedMon, 18 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50089674/FDA-Approves-Huntington-s-Disease-Treatment.aspxXenazine (tetrabenazine) from Prestwick Pharmaceuticals is the first medication indicated specifically for the condition.Estee Lauder Sees Net Sales Grow 8 Pct in 2008http://myprocessexpo365.packexpo.com/NST-8-50088809/Estee-Lauder-Sees-Net-Sales-Grow-8-Pct-in-2008.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedFri, 15 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50088809/Estee-Lauder-Sees-Net-Sales-Grow-8-Pct-in-2008.aspxNet earnings for the cosmetics and personal care giant were $473.8 million for the year ended June 30, 2008, compared with $449.2 million last year.Genentech Rejects Roche's $43.7B Bid for a Complete Takeoverhttp://myprocessexpo365.packexpo.com/NST-8-50088091/Genentech-Rejects-Roche-s-43-7B-Bid-for-a-Complete-Takeover.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedThu, 14 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50088091/Genentech-Rejects-Roche-s-43-7B-Bid-for-a-Complete-Takeover.aspxRoche already owns 56 percent of Genentech, the world biggest biotech company in terms of stock value and second biggest in revenue to Amgen of Thousand Oaks.IGI Laboratories to Manufacture Prescription Productshttp://myprocessexpo365.packexpo.com/NST-8-50088092/IGI-Laboratories-to-Manufacture-Prescription-Products.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedThu, 14 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50088092/IGI-Laboratories-to-Manufacture-Prescription-Products.aspxThe firm, which specializes in making OTC skin treatment products, is set to begin producing topical prescription medications.NanoMedex Moving to Wisconsinhttp://myprocessexpo365.packexpo.com/NST-8-50088093/NanoMedex-Moving-to-Wisconsin.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedThu, 14 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50088093/NanoMedex-Moving-to-Wisconsin.aspxThe pharmaceutical company is aiming to bring to market an improved formulation of a widely used anesthetic.CVS Caremark Buys Longs Drug Storeshttp://myprocessexpo365.packexpo.com/NST-8-50087624/CVS-Caremark-Buys-Longs-Drug-Stores.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedWed, 13 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50087624/CVS-Caremark-Buys-Longs-Drug-Stores.aspxCVS has said that it plans to rebrand most of the 581 stores in the Longs chain, which is concentrated in Northern and Central California.Pharmaceutical Giants Tracking Mylan's Prosperityhttp://myprocessexpo365.packexpo.com/NST-8-50087625/Pharmaceutical-Giants-Tracking-Mylan-s-Prosperity.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedWed, 13 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50087625/Pharmaceutical-Giants-Tracking-Mylan-s-Prosperity.aspxAfter its own recent acquisitions, the generic drug maker is increasingly the subject of takeover talks. FDA Approves Viread for Chronic Hepatitis B in Adultshttp://myprocessexpo365.packexpo.com/NST-8-50087076/FDA-Approves-Viread-for-Chronic-Hepatitis-B-in-Adults.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedTue, 12 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50087076/FDA-Approves-Viread-for-Chronic-Hepatitis-B-in-Adults.aspxGilead's drug has previously been approved for the treatment of hepatitis B in the European Union, Turkey, Australia and New Zealand.Vi-Jon Moves to Top of Private-Label Cosmetics Markethttp://myprocessexpo365.packexpo.com/NST-8-50086231/Vi-Jon-Moves-to-Top-of-Private-Label-Cosmetics-Market.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedMon, 11 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50086231/Vi-Jon-Moves-to-Top-of-Private-Label-Cosmetics-Market.aspxThe company has carved out a niche by making products that compete directly with brand offerings from titans like Procter & Gamble.FDA Approves Vapotherm Devicehttp://myprocessexpo365.packexpo.com/NST-8-50086268/FDA-Approves-Vapotherm-Device.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedMon, 11 Aug 2008 00:00:00 GMThttp://myprocessexpo365.packexpo.com/NST-8-50086268/FDA-Approves-Vapotherm-Device.aspxAbout 800 hospitals in the U.S. and more than 20 countries now use Vapotherm devices in neonatal, pediatric and adult units to treat chronic lung and acute breathing disorders.